Tosin Oyediran Global health researchers have urged Africans to embrace clinical trials, emphasising their vital role in addressing local health challenges and boosting economic opportunities. Ahead of the 2024 Impact Africa Summit in Lagos, the group of experts highlighted the need to create a robust and sustainable clinical trial ecosystem in Sub-Saharan Africa. They noted that this would enable the region to tackle diseases prevalent among its populations, attract global investment, and establish itself as a significant player in international health research.
In a press release on Wednesday, the organisers stressed that the summit will bring together researchers, healthcare practitioners, and policymakers to develop concrete strategies for advancing clinical trials in Sub-Saharan Africa. “The Impact Africa Summit is dedicated to unlocking the potential of clinical trials in Africa,” the statement read, describing the event as “a platform to set actionable goals for an empowered African health sector.” A project manager at Xcene Research, Dr Faramola Ogunkoya, explained the importance of the summit.
Ogunkoya said, “We must expand Africa’s role within the global pharmaceutical value chain by including Sub-Saharan Africa in clinical trials. “This summit is a critical step toward a healthier, more inclusive future through fostering partnerships and shared solutions.” Ogunkoya stressed that “clinical trials not only pave the way for tailored medical solutions.